It's an upgrade worth making, but it comes down to your privacy concerns.

Vitalik Buterin outlined the updated Lean Ethereum roadmap, a 3-to-4-year plan covering quantum resistance, 10,000 TPS ...

I navigated each of those disruptions inside HBO, one of the most beloved and high-profile cultural brands in the world. Bold ...

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

Ethereum co-founder Vitalik Buterin has detailed plans for a sweeping, multi-year transformation of the blockchain and smart contract focused protocol that he describes as the network’s third major ...

What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...

In the AI value chain, application-layer leaders like Palantir and ServiceNow may win long term as chip/cloud margins ...

The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?

With Sidewinder, Ares graduated from a scanner that followed a script to an adversary that thinks. Where Dagger marched every target through the same fixed sequence of phases on a single fine-tuned ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...